This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Röcken, C. Articles by Bühling, F. Search for Related Content PubMed PubMed Citation Articles by Röcken, C. Articles by Bühling, F.

(American Journal of Pathology. 2001;158:1029-1038.)
© 2001 American Society for Investigative Pathology

Regular Articles

A Putative Role for Cathepsin K in Degradation of AA and AL Amyloidosis

Christoph Röcken^*, Barbara Stix^*, Dieter Brömme, Siegfried Ansorge, Albert Roessner^* and Frank Bühling

From the Institutes of Pathology^*
and Immunology,
Otto-von-Guericke-University, Magdeburg, Germany; and the Mt. Sinai Medical School,
New York, New York

The aims of this study were to investigate the role of cathepsin K in the pathology of amyloidosis by demonstrating its presence in multinucleated giant cells (MGCs) adjacent to amyloid deposits, and determining its ability to degrade amyloid fibril proteins in vitro. The study was performed using autopsy and biopsy specimens from patients with AA or AL amyloidosis. In six (55%) patients with AA amyloidosis and seven (58%) patients with AL amyloidosis, variable numbers of CD68-immunoreactive MGCs were found adjacent to amyloid deposits. In each case strong cytoplasmic immunostaining for cathepsin K was found in MGCs; immunostaining of amyloid deposits was present in five (45%) patients with AA amyloidosis and three (25%) patients with AL amyloidosis. In vitro degradation experiments showed that recombinant cathepsin K completely degraded AA amyloid fibril proteins at pH 5.5 as shown by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting. Less effective degradation took place at pH 7.4 and there was no degradation in the presence of a general cysteine protease inhibitor (E64) or in the absence of cathepsin K. This is the first study to show that cathepsin K is expressed in MGCs adjacent to amyloid deposits and to demonstrate its ability to degrade amyloid fibril proteins.

This article has been cited by other articles:

				F. A. Jaffer, D.-E. Kim, L. Quinti, C.-H. Tung, E. Aikawa, A. N. Pande, R. H. Kohler, G.-P. Shi, P. Libby, and R. Weissleder Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor Circulation, May 1, 2007; 115(17): 2292 - 2298. [Abstract] [Full Text] [PDF]

				M. O. Platt, R. F. Ankeny, and H. Jo Laminar Shear Stress Inhibits Cathepsin L Activity in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1784 - 1790. [Abstract] [Full Text] [PDF]

				C. Rocken, J. Tautenhahn, F. Buhling, D. Sachwitz, S. Vockler, A. Goette, and T. Burger Prevalence and pathology of amyloid in atherosclerotic arteries. Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 676 - 677. [Full Text] [PDF]

				C Rocken, R Menard, F Buhling, S Vockler, J Raynes, B Stix, S Kruger, A Roessner, and T Kahne Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation Ann Rheum Dis, June 1, 2005; 64(6): 808 - 815. [Abstract] [Full Text] [PDF]

				B. Stix, M. Leber, P. Bingemer, C. Gross, J. Ruschoff, M. Fandrich, D. F. Schorderet, C. K. Vorwerk, M. Zacharias, A. Roessner, et al. Hereditary Lattice Corneal Dystrophy Is Associated with Corneal Amyloid Deposits Enclosing C-Terminal Fragments of Keratoepithelin Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1133 - 1139. [Abstract] [Full Text] [PDF]

				F. Buhling, C. Rocken, F. Brasch, R. Hartig, Y. Yasuda, P. Saftig, D. Bromme, and T. Welte Pivotal Role of Cathepsin K in Lung Fibrosis Am. J. Pathol., June 1, 2004; 164(6): 2203 - 2216. [Abstract] [Full Text] [PDF]

				F. Buhling, N. Waldburg, A. Reisenauer, A. Heimburg, H. Golpon, and T. Welte Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation Eur. Respir. J., April 1, 2004; 23(4): 620 - 628. [Abstract] [Full Text] [PDF]

				C. Rocken, R. Kientsch-Engel, S. Mansfeld, B. Stix, K. Stubenrauch, B. Weigle, F. Buhling, M. Schwan, and W. Saeger Advanced Glycation End Products and Receptor for Advanced Glycation End Products in AA Amyloidosis Am. J. Pathol., April 1, 2003; 162(4): 1213 - 1220. [Abstract] [Full Text] [PDF]

				C. Rocken, B. Peters, G. Juenemann, W. Saeger, H. U. Klein, C. Huth, A. Roessner, and A. Goette Atrial Amyloidosis: An Arrhythmogenic Substrate for Persistent Atrial Fibrillation Circulation, October 15, 2002; 106(16): 2091 - 2097. [Abstract] [Full Text] [PDF]

				B. Stix, T. Kahne, K. Sletten, J. Raynes, A. Roessner, and C. Rocken Proteolysis of AA Amyloid Fibril Proteins by Matrix Metalloproteinases-1, -2, and -3 Am. J. Pathol., August 1, 2001; 159(2): 561 - 570. [Abstract] [Full Text]